Considerations of Sex and Gender in FDA Tobacco Regulation
JAMA · 2023
DOI: 10.1001/jama.2023.6803 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, 2023. Verfasst von Danielle R Davis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut. Hauptthemen laut MEDLINE: Tobacco Control, Tobacco Industry, Tobacco Products. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS.
Abstract (Originalsprache)
This Viewpoint discusses how sex and gender subpopulations may be differentially affected by tobacco products and suggests that the FDA formulate regulations in clinically meaningful ways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut.
- Department of Psychology, Yale School of Medicine, New Haven, Connecticut.
Förderung
- NIDA NIH HHS
Zitieren
APA
Davis, D. R., Krishnan-Sarin, S., & Mazure, C. M. (2023). Considerations of Sex and Gender in FDA Tobacco Regulation. JAMA. https://doi.org/10.1001/jama.2023.6803
Vancouver
Davis DR, Krishnan-Sarin S, Mazure CM. Considerations of Sex and Gender in FDA Tobacco Regulation. JAMA. 2023. doi:10.1001/jama.2023.6803
BibTeX
@article{Davis2023,
author = {Davis, Danielle R and Krishnan-Sarin, Suchitra and Mazure, Carolyn M},
title = {Considerations of Sex and Gender in FDA Tobacco Regulation},
journal = {JAMA},
year = {2023},
doi = {10.1001/jama.2023.6803}
}
EUVIMED